Inspiration Healthcare Group PLC Director/PDMR Shareholding (0807C)
16 June 2021 - 6:18PM
UK Regulatory
TIDMIHC
RNS Number : 0807C
Inspiration Healthcare Group PLC
16 June 2021
16 June 2021
INSPIRATION HEALTHCARE GROUP PLC
("IHG" or the "Company")
PDMR Dealing
The Company has been notified that on 9 June 2021, Toby Foster,
the Managing Director of the Company's wholly owned subsidiary,
Inspiration Healthcare Limited and a person discharging managerial
responsibility ("PDMR") in the Company, made a transfer for nil
consideration of 500,000 ordinary shares of 10 pence each in the
Company ("Ordinary Shares") to his spouse, Nia Foster, a person
closely associated ("PCA") with Toby Foster (the "Transfer").
Following the Transfer, Mr Foster will directly hold 3,415,283
Ordinary Shares, with no change to his total beneficial holding,
including those held by his wife as a PCA, of 3,915,283 Ordinary
Shares.
This announcement, including the notification below, is made in
accordance with the requirements of the EU Market Abuse
Regulation.
1 Details of the person discharging managerial responsibilities/person
closely associated
a. Name Toby Foster
------------------------------------------------------------
2 Reason for notification
-------------------------- ------------------------------------------------------------
a. Position/Status Managing Director of Inspiration Healthcare
Limited
-------------------------- ------------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
-------------------------- ------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name INSPIRATION HEALTHCARE GROUP PLC
--------------------------
b. LEI 213800GKFT3ENAPMDL15
-------------------------- ------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Ordinary Shares of 10 p each
the financial
instrument, type ISIN: GB00BXDZL105
of instrument
Identification
Code
-------------------------- ------------------------------------------------------------
b. Nature of the Transfer of Ordinary Shares to spouse
transaction
-------------------------- ------------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
-------------------------- --------------------
Nil consideration 500,000
-------------------------------------------------------- -----------
d. Aggregated information N/A
- Aggregated Volume
- Price
-------------------------- ------------------------------------------------------------
e. Date of the transaction 9 June 2021
-------------------------- ------------------------------------------------------------
f. Place of the transaction XLON (AIM)
-------------------------- ------------------------------------------------------------
Enquiries:
Inspiration Healthcare Group plc Tel: 01455 840
Neil Campbell, Chief Executive Officer 555
Jonathan Ballard, Chief Financial Officer
Cenkos Securities plc - Nominated Adviser Tel: 0207 397 8900
& Broker
Mark Connelly / Stephen Keys
Cadogan PR Tel: 07771 713
Alex Walters 608
alex.walters@cadoganpr.com
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of
medical technology for use in critical care & operating
theatres. The Company provides high quality innovative products to
patients around the world which help to improve patient outcomes
and it actively invests in innovative product opportunities and
disruptive technologies.
Through investment in research and development the Company has 6
key own brand products that can be used within the first 6 hours of
life to help premature and sick babies; helping with assessment,
resuscitation, stabilisation as well as preventing brain damage.
Additionally, the Company has its own range of products for
maintaining normothermia pre- during and post-surgery.
With product availability extending to over 50 countries through
a distribution network, Inspiration Healthcare's success has been
built on continuous innovation, excellent customer service and an
inherent commitment to improving patient outcomes, working in close
collaboration with key opinion leaders across the globe.
In the UK and Ireland, the Company has a direct sales team
selling Inspiration Branded and complementary products from third
parties, with an additional range of home healthcare products. This
is supported by Technical Support for planned preventative
maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at
www.inspiration-healthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFIFLTRDIRLIL
(END) Dow Jones Newswires
June 16, 2021 04:18 ET (08:18 GMT)
Inspiration Healthcare (LSE:IHC)
Historical Stock Chart
From Apr 2024 to May 2024
Inspiration Healthcare (LSE:IHC)
Historical Stock Chart
From May 2023 to May 2024